WO2026062615 - A METHOD FOR THE PRODUCTION OF RECOMBINANT FUSION PROTEIN
National phase entry is expected:
Publication Number
WO/2026/062615
Publication Date
26.03.2026
International Application No.
PCT/IB2025/059556
International Filing Date
23.09.2025
Title **
[English]
A METHOD FOR THE PRODUCTION OF RECOMBINANT FUSION PROTEIN
[French]
PROCÉDÉ DE PRODUCTION DE PROTÉINE DE FUSION RECOMBINANTE
Applicants **
KASHIV BIOSCIENCES, LLC
Inventors
RAI, Toyaj
SHAH, Viral J
GUPTA, Sudharti
Priority Data
202421071746
23.09.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3637 | |
| EPO | Filing, Examination, Granting | 43100 | |
| Japan | Filing, Examination, Granting | 3571 | |
| South Korea | Filing, Examination, Granting | 5052 | |
| USA | Filing, Examination, Granting | 17110 |
Total:
72,470
Contact Us
Abstract[English]
The present disclosure relates to a method for high yield expression of recombinant fusion proteins and a system thereof. The invention encompasses the development and utilization of a novel expression vector construct that significantly enhances the expression and yield of the protein of interest. The expression vector construct encodes nucleotide sequence fusion protein and other regulatory elements. Further, the expression vector construct provides high expression more than 2 gm/L with desired quality of fusion protein.[French]
La présente divulgation concerne un procédé d'expression à haut rendement de protéines de fusion recombinantes et un système associé. L'invention englobe la mise au point et l'utilisation d'une nouvelle construction de vecteur d'expression qui améliore considérablement l'expression et le rendement de la protéine d'intérêt. La construction de vecteur d'expression code une protéine de fusion de séquence nucléotidique et d'autres éléments régulateurs. En outre, la construction de vecteur d'expression fournit une expression élevée supérieure à 2 gm/l présentant une qualité souhaitée de protéine de fusion.